Myriad Genetics, Inc. announced the appointment of Jennifer Fox as Chief Legal Officer, effective September 3, 2024. Fox brings nearly two decades of legal experience in the life sciences sector. Her expertise spans intellectual property, litigation, and regulatory matters, gained through roles in both in-house and private practice settings at industry-leading companies.

As Chief Legal Officer, Fox?s responsibilities will encompass a wide range of areas, including support and counsel for all legal affairs, intellectual property, patent protection, mergers and acquisitions, litigation, regulatory and quality assurance, compliance, privacy, and government affairs. Fox most recently served as the Executive Vice President of External Affairs for Emergent BioSolutions where she was responsible for overseeing legal functions, government and public affairs, communications, and ESG initiatives. Prior to that role, she held positions with Brinks, Gilson & Lione, Novozymes North America and GSK.

Fox holds a J.D. from North Carolina Central University, an M.S. in Biochemistry and Molecular Biology from the University of Toledo, and a B.S. in Biology, also from the University of Toledo.